Home/Filings/4/0001181431-07-038086
4//SEC Filing

JAZZ PHARMACEUTICALS INC 4

Accession 0001181431-07-038086

$JAZZCIK 0001232524operating

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 11:06 AM ET

Size

7.2 KB

Accession

0001181431-07-038086

Insider Transaction Report

Form 4
Period: 2007-06-06
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
  • Conversion

    Common Stock

    2007-06-06+66,26496,082 total
  • Conversion

    Series B Preferred Stock

    2007-06-0666,2640 total
    Common Stock (66,264 underlying)
Footnotes (2)
  • [F1]The Issuer's Preferred Stock automatically converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and had no expiration date.
  • [F2]Includes 2,485 shares subject to the Issuer's unvested share repurchase right as of May 30, 2007.

Issuer

JAZZ PHARMACEUTICALS INC

CIK 0001232524

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001232524

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 11:06 AM ET
Size
7.2 KB